Qiming Venture Partners

Shanghai Biotree Biotech Co., Ltd. specializes in the development and application of life science research technologies. Founded in 2013, the company is based in Shanghai, China, and focuses on sample testing, big data analysis, and technical product development within the life sciences sector. It offers a range of professional services tailored to universities, research institutes, hospitals, and enterprises. Biotree is particularly noted for its expertise in metabolomics, providing early detection and analysis services, as well as consulting related to mass spectrometry and metabolic testing. The company has a strong portfolio of patents in metabolomics and continues to innovate in product development and technology within this field. Since its inception, Biotree has demonstrated consistent growth and profitability, establishing itself as a key player in the domestic metabolomics detection and analysis market.

Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through innovative digital technologies and the application of artificial intelligence. Prime Lifescience offers a range of services, including a digital smart health community, a digital intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions framework within the healthcare industry, leveraging extensive data to improve health outcomes.

Sinogen Biopharma is a biotechnology company dedicated to connecting China's innovative drug development with the pharmaceutical market in the United States. The company specializes in the licensing and development of bacterial carrier-based biological anti-tumor drugs aimed at treating malignant tumors, particularly in the area of metastatic tumors and rare diseases. By focusing on the creation of innovative anti-cancer therapies, Sinogen Biopharma seeks to address the needs of both domestic and international pharmaceutical markets.

Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Hayward, California.

PlusLife Biotech is devoted to developing revolutionary molecular diagnostic tools and gene treatment programs employing a new generation of gene technology. Founded in 2017 and is based in Guangzhou, China.

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Yidao Biotechnology (Suzhou) Co., Ltd., established in 2017 and based in Suzhou, China, specializes in the research and development of biomedicine, with a particular emphasis on vaccines. The company focuses on creating a diverse range of vaccine types, including recombinant protein antigen vaccines, new virus vector vaccines, messenger RNA vaccines, and vaccine adjuvant platforms. Yidao Biotechnology aims to address the health needs of both domestic and international markets through its innovative vaccine solutions.

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Basecamp Bio is a cell and gene therapy research and development company that develops cell and gene therapies, regenerative medicine, and immunotherapies.

Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Hayward, California.

Luc Therapeutics, founded in 2010 and based in Cambridge, Massachusetts, was a precision neuroscience company focused on developing novel allosteric modulators for ion channels aimed at improving neuronal firing regularity. The company specialized in creating subunit-selective NMDA receptor modulators, including NR2B negative allosteric modulators for depression and NR2B positive allosteric modulators to enhance cognitive function in schizophrenia. Additionally, it explored NR2A negative allosteric modulators to address disease progression and symptoms in Rett syndrome and other autism spectrum disorders. Luc Therapeutics was known for its innovative approach to restoring cognitive and motor functions in patients with serious neurological conditions by leveraging target specificity, patient selection, and drug optimization. In October 2017, Luc Therapeutics changed its name to Cadent Therapeutics.

Bioscience integrates R&D, manufacture, marketing and provides related technical supports for IVD instruments and reagents.

Founded in May 2010, Berry Genomics is the leading genomics company specializing in developing and commercializing technologies for life sciences and clinical applications. Among the clinical applications, the company is dedicated to developing next generation sequencing (NGS) based tests for genetic disease and cancer from preconception to adulthood.

Element Science, Inc. is a medical device and digital health company focused on developing solutions for high-risk cardiovascular patients. The company's flagship product is a patch-based wearable cardioverter defibrillator that continuously monitors heart activity to protect against sudden cardiac death. This device integrates advanced data science and machine learning algorithms with strict electromechanical medical device standards, creating a proprietary digital platform that enhances patient care as individuals transition from hospital to home. Founded in 2011 and headquartered in San Francisco, California, Element Science aims to address critical health needs and reduce hospitalization rates associated with heart disease. The company was previously known as Revive Defibrillation Systems, Inc. before adopting its current name in 2014.

Luc Therapeutics, founded in 2010 and based in Cambridge, Massachusetts, was a precision neuroscience company focused on developing novel allosteric modulators for ion channels aimed at improving neuronal firing regularity. The company specialized in creating subunit-selective NMDA receptor modulators, including NR2B negative allosteric modulators for depression and NR2B positive allosteric modulators to enhance cognitive function in schizophrenia. Additionally, it explored NR2A negative allosteric modulators to address disease progression and symptoms in Rett syndrome and other autism spectrum disorders. Luc Therapeutics was known for its innovative approach to restoring cognitive and motor functions in patients with serious neurological conditions by leveraging target specificity, patient selection, and drug optimization. In October 2017, Luc Therapeutics changed its name to Cadent Therapeutics.

MicroPoint Bioscience, Inc. (微点生物) is a Chinese company dedicated to biochip research and development. The company offers a product series, Lab On a Chip, which is based on micro-electronic mechanical technologies. MicroPoint Biosciences customizes demanded products and services for customers in areas of human health such as medicine, environmental protection, food safety, scientific research, and other application areas. In the area of medicine, MicroPoint Company's bedside immediate diagnosis chip and examination instrument provides low-cost resolutions for early diagnosis and the process monitoring of vascular diseases, tumors, emergency treatments, and operations.

Founded in May 2010, Berry Genomics is the leading genomics company specializing in developing and commercializing technologies for life sciences and clinical applications. Among the clinical applications, the company is dedicated to developing next generation sequencing (NGS) based tests for genetic disease and cancer from preconception to adulthood.

Bioscience integrates R&D, manufacture, marketing and provides related technical supports for IVD instruments and reagents.

ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics. The company is based in Redwood City, California.

Kezar Life Sciences, Inc. is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing novel small molecule therapeutics for unmet medical needs in autoimmunity and cancer. The company’s lead candidate, KZR-616, is a selective immunoproteasome inhibitor currently undergoing Phase 2 clinical trials for multiple autoimmune conditions, including lupus nephritis and autoimmune hemolytic anemia, as well as Phase 1b/2 trials for systemic lupus erythematosus. In addition to KZR-616, Kezar is advancing preclinical products, including KZR-TBD, aimed at treating oncology and autoimmune disorders. Founded in 2015, Kezar Life Sciences leverages insights into protein homeostasis, particularly the interplay between protein degradation and secretion, to drive its drug discovery efforts.

Sinocelltech Group Limited is a biotechnology company based in Beijing, China, specializing in the development and production of biopharmaceutical products, including recombinant proteins, monoclonal antibodies, and vaccines. The company has established advanced technology platforms that encompass protein expression vectors, cell line development, serum-free medium development, and stoichiometrically controlled fed-batch cell culture. Sinocelltech focuses on the industrialization of its products, offering capabilities in stable CHO cell line development, cell banking, and certification, as well as optimization and large-scale production processes. The company's mission is to enhance access to life-saving biological medications by continually improving manufacturing technologies to reduce development and production costs.

Founded in May 2010, Berry Genomics is the leading genomics company specializing in developing and commercializing technologies for life sciences and clinical applications. Among the clinical applications, the company is dedicated to developing next generation sequencing (NGS) based tests for genetic disease and cancer from preconception to adulthood.

MedSci provides strategies, solutions and services to pharmaceutical, biotech and medical device organization and the consumer healthcare industry

BBI Life Sciences Corporation is one of the leading providers with the widest portfolio coverage in the life sciences research products and services industry in China. Their comprehensive product and service portfolio for life sciences research has an extensive range of applications, including (i) DNA synthesis products, (ii) genetic engineering services, (iii) life sciences research consumables; and (iv) protein and antibody related products and services. Their customers include colleges and universities, research institutes, hospitals, pharmaceutical and biotech companies, government testing and diagnostic centres, as well as distribution companies in China and overseas. Moreover, their Sangon and BBI brands have become highly recognisable in the market based on product and service quality, price competitiveness, and express delivery services. In terms of revenue in 2013, they are the largest provider of DNA synthesis products in China, and also ranked first among oligonucleotide synthesis product providers as a sub-segment of DNA synthesis products.

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

Founded in May 2010, Berry Genomics is the leading genomics company specializing in developing and commercializing technologies for life sciences and clinical applications. Among the clinical applications, the company is dedicated to developing next generation sequencing (NGS) based tests for genetic disease and cancer from preconception to adulthood.

OriGene Technologies, Inc. specializes in the development, manufacturing, and sale of genome-wide research and diagnostic products tailored for academic, pharmaceutical, and biotechnology applications. Founded with a focus on creating a comprehensive collection of full-length human cDNAs, the company offers a diverse range of products, including cDNA clones, shRNA and siRNA tools, and CRISPR/Cas9 genome editing products. Additionally, OriGene provides proteins and lysates, an extensive array of antibodies for immunohistochemistry, and various assay kits, including ELISA and luminex kits. The company supports critical biological research by supplying essential resources for cancer biomarker studies, stem cell research, and other areas. With a commitment to facilitating gene-based research, OriGene distributes its products globally through distributors and online channels. Established in 1995 and based in Rockville, Maryland, OriGene continues to enhance its offerings to meet the evolving needs of researchers in the life sciences field.

Beijing Centre Biology Co., Ltd. is a high-technology company based in Beijing, China, specializing in the research, development, manufacture, and sale of animal health products. Founded in 1999, the company offers a diverse range of products including herbal veterinary drugs, vaccines, chemical drugs, and feed additives. Its portfolio encompasses liquid injections, powders for injection, oral solutions, tablets, and premixes designed for farm animals, alongside food and nutrition products for pets such as dogs, cats, and pigeons. The company serves various segments including poultry and livestock breeding bases, large-scale breeding enterprises, and wholesalers throughout China. Additionally, Beijing Centre Biology exports its products to around 40 countries across Europe, South America, Asia, and Africa, ensuring compliance with national quality standards and food safety requirements.

Gan & Lee Pharmaceutical, Ltd., a biopharmaceutical company, engages in the research, development, production, and commercialization of biosynthetic human insulin and analogues primarily in China. Its products include Basalin, an insulin glargine injection; and Prandilin, an insulin lispro injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceutical, Ltd. in April 2005. Gan & Lee Pharmaceutical, Ltd. was founded in 1998 and is headquartered in Beijing, China.

Beijing Centre Biology Co., Ltd. is a high-technology company based in Beijing, China, specializing in the research, development, manufacture, and sale of animal health products. Founded in 1999, the company offers a diverse range of products including herbal veterinary drugs, vaccines, chemical drugs, and feed additives. Its portfolio encompasses liquid injections, powders for injection, oral solutions, tablets, and premixes designed for farm animals, alongside food and nutrition products for pets such as dogs, cats, and pigeons. The company serves various segments including poultry and livestock breeding bases, large-scale breeding enterprises, and wholesalers throughout China. Additionally, Beijing Centre Biology exports its products to around 40 countries across Europe, South America, Asia, and Africa, ensuring compliance with national quality standards and food safety requirements.

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

Gan & Lee Pharmaceutical, Ltd., a biopharmaceutical company, engages in the research, development, production, and commercialization of biosynthetic human insulin and analogues primarily in China. Its products include Basalin, an insulin glargine injection; and Prandilin, an insulin lispro injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceutical, Ltd. in April 2005. Gan & Lee Pharmaceutical, Ltd. was founded in 1998 and is headquartered in Beijing, China.

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

Shanghai Sangon Biological Engineering Technology & Services Co., Ltd. supplies biochemical research products and services. Its products include biochemicals, aminoacid, antibiotics, biological and electrophoresis buffers, blotting paper and membranes, medium, dyes and indicators, molecular biology kits, PCR related products, restriction endonuclease, DNA and RNA modified enzymes, DNA vector, labwares, and small instruments, as well as RNA, DNA, and protein markers. The company also provides DNA synthesis and sequencing, as well as gene and peptide synthesis. It offers products through distributors in China, Africa, and South America. The company was founded in 1995 and is based in Shanghai, China.

Gan & Lee Pharmaceutical, Ltd., a biopharmaceutical company, engages in the research, development, production, and commercialization of biosynthetic human insulin and analogues primarily in China. Its products include Basalin, an insulin glargine injection; and Prandilin, an insulin lispro injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceutical, Ltd. in April 2005. Gan & Lee Pharmaceutical, Ltd. was founded in 1998 and is headquartered in Beijing, China.

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.